| Product Name | CRSP150 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | MED14 antibody; ARC150 antibody; CRSP2 antibody; CXorf4 antibody; DRIP150 antibody; EXLM1 antibody; RGR1 antibody; TRAP170 antibody; Mediator of RNA polymerase II transcription subunit 14 antibody; Activator-recruited cofactor 150 kDa component antibody; ARC150 antibody; Cofactor required for Sp1 transcriptional activation subunit 2 antibody; CRS antibody; |
| Product description | The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e. g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. This protein contains a bipartite nuclear localization signal. This gene is known to escape chromosome X-inactivation. |
| Immunogen | The antiserum was produced against synthesized peptide derived from human MED14. AA range:701-750 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | IHCIF |
| IHC:1:100-1:300 IF:1:100-1:500 |
|
| Species Reactivity | HumanMouse |
| Concentration | 1mg/ml |
| Alternative Names | MED14 antibody ARC150 antibody CRSP2 antibody CXorf4 antibody DRIP150 antibody EXLM1 antibody RGR1 antibody TRAP170 antibody Mediator of RNA polymerase II transcription subunit 14 antibody Activator-recruited cofactor 150 kDa component antibody ARC150 antibody Cofactor required for Sp1 transcriptional activation subunit 2 antibody CRS antibody |
|---|---|
| Molecular Weight(MW) | kDa |
| SwissProt ID | O60244 |
|---|
| Positive Control | Cervix carcinoma,Epithelium,Placenta, |
|---|---|
| Application Notes | IHC:1:100-1:300 IF:1:100-1:500 |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
| Storage Buffer | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
